ClinicalTrials.gg
Sign In

Colonic Diseases clinical trials

The registry lists 159 studies for Colonic Diseases across more than 10 countries. 21 are recruiting or about to start. 72 of them are mainly about Colonic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 19 narrower conditions too, such as Colorectal Neoplasms: 13,241 studies, 3,409 open.

Get an email when these change. Save the Colonic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
99
Status unknown
21
Recruiting
15
Terminated
11
Not yet recruiting
6
Active, not recruiting
5

Phase

Phase 2
21
Phase 3
21
Phase 4
10
Phase 1
10

Where

United States
53
Spain
19
Canada
18
Italy
17
China
16
Netherlands
11

Who runs them

Medtronic - MITG (10) · Exact Sciences Corporation (6) · Parc de Salut Mar (6) · Pharmbio Korea Co., Ltd. (4) · Bausch Health Americas, Inc. (4) · University Hospitals Cleveland Medical Center (4) · gicare Pharma Inc. (3) · Astellas Pharma Inc (3)

What is being tested here

Drugs under test in Colonic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ascorbic Acid103
Polyethylene glycol 3350102
Anti-PD-1/Anti-VEGF Bispecific Antibody PF-08634404111
Repotrectinib101
Sodium sulfate101
Sodium Chloride101
Potassium Chloride101
Trimebutine 3-thiocarbamoylbenzenesulfonate003
Ramosetron003
Oxaliplatin012

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open

Coming up

5phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 15 Colonic Diseases studies recruiting now, 12 (80%) set no upper age limit and 3 (20%) stop at 75 or younger. 1 (7%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (20%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
100 (0%)0 (0%)
1813 (87%)13 (87%)
3014 (93%)14 (93%)
4014 (93%)14 (93%)
5015 (100%)15 (100%)
6515 (100%)15 (100%)
7514 (93%)14 (93%)
8512 (80%)12 (80%)

Across all 159 studies, recruiting or not: 28% stop at 75 or younger and 11% at 65; 5% take children; 1% are for women only and 1% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Colonic Diseases studies take

Of 32 interventional studies with no phase under Colonic Diseases, half reached primary completion within 19 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase19 mo10–30 · 32 studies—19 mo6–32 · 28 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 159. Browse all 159 → or search them.